Logo BcnPit

Barcelona – Pittsburgh

XII Biennial Conference Barcelona Pittsburgh
1-3 de Junio 2022
Todo el día
Streaming Online
La Pedrera

¡Bienvenidos a la XII Conferencia Bienal Barcelona – Pittsburgh!

Te unes a una conferencia que se ha convertido en una referencia en el campo de las demencias. Este año, en junio de 2022, BCNPIT volverá a surgir como un valioso foro donde profesionales de todo el mundo se conectan y comparten su trabajo y perspectivas sobre la demencia.

Se trata de un congreso de gran calidad que reúne a panelistas de reconocido prestigio científico internacional y crea un espacio interactivo relacionado con la neurociencia cuyo objetivo final es beneficiar a las personas afectadas y sus familias.


Dr. Butler research focusses on understanding the memory deficits experienced by patients with damage to the medial temporal lobes of the brain

Chris Butler, MD, PhD Clinical Senior Lecturer in Neurology at the Imperial College

Vitorica’s group main goal is the characterization of transgenic mice models of AD at the cellular and molecular levels.

Javier Vitorica, PhD Principal researcher at Ciberned

The Neurochemistry Laboratory of VUmc aims at developing biomarkers for neurodegenerative diseases.

Charlotte Teunissen, PhD Professor in Neurochemistry at VUmc

Currently, Dr. Costa is Director of Plasma Proteins Research of the Grifols Bioscience Research Group, where she is in charge of leading Alzheimer’s Disease research.

Montse Costa, PhD Director of the Plasma Proteins Research at the R&D Grifols

Dr. Vellas main interests are: development of aging and geriatric clinical research and care.

Bruno Vellas, MD, PhD Department of Geriatric Internal Medicine at the Toulouse University Hospital

Dr. Ikram’s research focuses on investigating the etiology of neurologic diseases in the elderly, with a particular focus on dementia, Alzheimer disease, stroke, and Parkinson disease.

Arfan Ikram, MD, PhD Professor and Chair Epidemiology at the Erasmus University Medical Center

The Kristel Sleegers lab is committed to increase insight in the complex genetics of Alzheimer’s disease and to investigate the translational potential of genetic discovery.

Kristel Sleegers, MD, PhD Full professor of Genetic Neuroepidemiology at the University of Antwerp

Prof. Heneka is involved in basic science and translational research with focus on neurodegeneration and neuroinflammation.

Prof. Michael Heneka, MD Director of the Luxembourg Centre for Systems Biomedicine

Dr. Cohen’s research interests include aging, Alzheimer’s disease and neuroimaging.

Ann D Cohen, PhD Associate Professor at the University of Pittsburgh

Dr. Seshadri enjoys a superb reputation in both science and clinical care and is a recognized thought leader in Alzheimer’s disease.

Sudha Seshadri, MD Founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases

Dr. Zlokovic studies the role of brain microcirculation, particularly the blood-brain barrier (BBB) in health and disease in the adult brain and during brain aging.

Berislav V Zlokovic, MD, PhD Director of the Zilkha Neurogenetic Institute

Dr. Cano is in charge of the molecular biology unit of Ace Alzheimer Center Barcelona and her studies are related to the clinical evaluation of early biomarkers of Alzheimer’s disease.

Amanda Cano, PhD Postdoctoral researcher at Ace

Dr. Alegret has extensive experience in diagnosis, clinical management, neuropsychological evaluation, cognitive stimulation and research on different neurodegenerative diseases

Montse Alegret, PhD Neuropsychologist at Ace

Neurologist specialist in cognitive disorders with a broad clinical and research experience in Spain and the United States.

Marta Marquié, MD, PhD Neurologist at Ace

The main objective of his genomic research group is to understand the causes of Alzheimer’s disease and other dementias by integrating genetic, transcriptomic and proteomic data.

Agustín Ruiz, MD, PhD Chief Scientific Officer at Ace
Ver Streaming
9:00 - 9:20
Keynote Lecture
The WHO ICOPE program and early diagnosis of Alzheimer
Ver Streaming
9:20 - 9:40
Keynote Lecture
Prediction of dementia by blood and PET biomarkers change over a period of 10 years
Ver Streaming
9:40 - 10:10
Keynote Lecture
Molecular imaging of amyloid, tau and neuroinflammation in Alzheimer’s disease.
Ver Streaming
10:10 - 10:25
10:10 - 10:25
Amyloid PET in Subjective Cognitive Decline: experience from the FACEHBI cohort
10:25 - 10:40
10:25 - 10:40
Integrating standard and novel MRI measures to measure neurodegeneration and cerebrovascular disease across the spectrum of AD
Coffee Break
Ver Streaming
11:15 - 11:30
11:15 - 11:30
Transcranial magnetic stimulation: a new approach to treat neurodegenerative diseases
11:30 - 11:45
11:30 - 11:45
Transcranial Ultrasound Stimulation: a novel method for non-invasive brain stimulation in health and disease
Ver Streaming
11:45 - 12:05
Keynote Lecture
Transcranial Pulse Stimulation TPS - a novel add on therapy for neurodegeneration
Ver Streaming
12:05 - 12:30
Keynote Lecture
Overview of global Pipelines
Ver Streaming
12:30 – 12:50
12:30 – 12:50
Development of therapeutics in Alzheimer’s disease
12:50 – 13:10
12:50 – 13:10
Top line data phase 2 study of ABvac40, an active vaccine anti-Aβ40 in patients with mild cognitive impairment or very-mild Alzheimer’s disease
13:10 – 13:30
13:10 – 13:30
Lessons learned: Developing gantenerumab as an Alzheimer's disease modifying therapy
Ver Streaming
13:30 – 14:00
Introduced by Ace Alzheimer Center Barcelona & University of Pittsburgh representatives


Otros colaboradores
Barcelona-Pittsburgh Conference
Pg. de Gràcia, 92, 08008 Barcelona Direcciones en Google Maps
93 430 47 20

No pierdas la oportunidad de ser parte de una de las comunidades más grandes en el campo de la demencia. Únete a la XII Conferencia Bienal Barcelona Pittsburgh

BcnPit Registro